For instance, in acute myeloid leukemia (AML), XBP1s was shown to transcriptionally upregulate miR-22-3p by directly targeting its host gene, MIR22HG, leading to downregulation of SIRT1 and increased chemosensitivity [36]. The gene discussed is SIRT1; the disease is acute myeloid leukemia.